Warning for UK CBD industry as regulator sets approval deadline
Products containing cannabis extract cannabidiol (CBD) are set to be “taken off the shelves” next year if they fail to gain regulatory approval.
The Food Standards Agency (FSA) has announced that products must be officially registered by March 2021 to avoid being withdrawn.
The CBD industry has grown in the UK over the past several years, with consumers using CBD oils, snacks and and drinks for a range of medicinal purposes, including pain relief and to combat insomnia.
Despite the growing popularity of the non-psychoactive substance, no products in the UK have yet been approved by FSA standards.
The agency has also issued new advice on the use of CBD, including information on interactions with medication.
FSA boss Emily Miles explained: “The CBD industry must provide more information about the safety and contents of these products to the regulator by March 2021, or the products will be taken off the shelves.”
Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.
Zero per cent - but maximum brand exposure
We don’t talk about money stress enough
A year of resilience, growth and collaboration
Apprenticeships: Lower standards risk safety
Keeping it reel: Creating video in an authenticity era
Budget: Creating a more vibrant market economy
Celebrating excellence and community support
The value of nurturing homegrown innovation
A dynamic, fair and innovative economy
Navigating the property investment market
Have stock markets peaked? Tune out the noise
Will the Employment Rights Bill cost too much?